BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35978969)

  • 1. Generalized structural equation modeling: Symptom heterogeneity in attention-deficit/hyperactivity disorder leading to poor treatment efficacy.
    Tzang RF; Chang YC
    World J Psychiatry; 2022 Jun; 12(6):787-800. PubMed ID: 35978969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Equation Modeling (SEM): Childhood Aggression and Irritable ADHD Associated with Parental Psychiatric Symptoms.
    Tzang RF; Chang YC; Chang CH
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
    Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Bullying Victimization and Quality of Life in Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) in Taiwan: Mediation of the Effects of Emotional Problems and ADHD and Oppositional Defiant Symptoms.
    Lin CW; Lee KH; Hsiao RC; Chou WJ; Yen CF
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Naturalistic Comparison of Methylphenidate and Risperidone Monotherapy in Drug-Naive Youth With Attention-Deficit/Hyperactivity Disorder Comorbid With Oppositional Defiant Disorder and Aggression.
    Masi G; Manfredi A; Nieri G; Muratori P; Pfanner C; Milone A
    J Clin Psychopharmacol; 2017 Oct; 37(5):590-594. PubMed ID: 28806385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children.
    Tzang RF; Chang YC; Tsai GE; Lane HY
    J Psychopharmacol; 2016 Oct; 30(10):976-82. PubMed ID: 27443598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An open trial on effectiveness of parent training in children with comorbid attention deficit hyperactivity disorder and oppositional defiant disorder].
    Liu J; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):310-4. PubMed ID: 17572790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased attention deficit/hyperactivity and oppositional defiance symptoms of 6-12 years old Chinese children with atopic dermatitis.
    Feng LJ; Chen AW; Luo XY; Wang H
    Medicine (Baltimore); 2020 Jun; 99(25):e20801. PubMed ID: 32569226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Psychosocial Outcome of Conduct and Oppositional Defiant Disorder in Children With Attention Deficit Hyperactivity Disorder.
    Eskander N
    Cureus; 2020 Aug; 12(8):e9521. PubMed ID: 32905151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.
    Gadow KD; Arnold LE; Molina BS; Findling RL; Bukstein OG; Brown NV; McNamara NK; Rundberg-Rivera EV; Li X; Kipp HL; Schneider J; Farmer CA; Baker JL; Sprafkin J; Rice RR; Bangalore SS; Butter EM; Buchan-Page KA; Hurt EA; Austin AB; Grondhuis SN; Aman MG
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):948-959.e1. PubMed ID: 25151418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROC Analyses of Relevant Conners 3-Short Forms, CBCL, and TRF Scales for Screening ADHD and ODD.
    Gomez R; Vance A; Watson S; Stavropoulos V
    Assessment; 2021 Jan; 28(1):73-85. PubMed ID: 31535569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical symptoms and performance on the Continuous Performance Test in children with attention deficit hyperactivity disorder between subtypes: a natural follow-up study for 6 months.
    Wang LJ; Huang YS; Chiang YL; Hsiao CC; Shang ZY; Chen CK
    BMC Psychiatry; 2011 Apr; 11():65. PubMed ID: 21504587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
    Golubchik P; Shalev L; Tsamir D; Manor I; Weizman A
    Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifactor latent structure of attention-deficit/hyperactivity disorder (ADHD)/oppositional defiant disorder (ODD) symptoms and first-order latent structure of sluggish cognitive tempo symptoms.
    Lee S; Burns GL; Beauchaine TP; Becker SP
    Psychol Assess; 2016 Aug; 28(8):917-28. PubMed ID: 26502205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of phthalates exposure with attention deficits hyperactivity disorder: A case-control study among Chinese children.
    Hu D; Wang YX; Chen WJ; Zhang Y; Li HH; Xiong L; Zhu HP; Chen HY; Peng SX; Wan ZH; Zhang Y; Du YK
    Environ Pollut; 2017 Oct; 229():375-385. PubMed ID: 28614761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant Disorder.
    Golubchik P; Weizman A
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):429-432. PubMed ID: 28398816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.